Recent Finacing
Recent Raise
Immuron develops and commercializes oral immunotherapeutics for gut-mediated diseases (e.g., Travelan) and pursues organic growth, M&A, and partnerships for reciprocal distribution, joint R&D, and expanded product-market reach including IBS.